Stop by Booth #3809 to access a full range of holistic analytical support, with services that span every stage of your path to market.
Essential Drug Delivery Output Is the New Essential Performance Requirement
Jennifer Riter, Vice President of Analytical and Development Services
The FDA’s updated draft guidance on Essential Performance Requirements (EPRs) offers key recommendations for combination product compliance. Attend this presentation to unlock strategies for navigating these requirements, with a focus on identifying and gathering data related to Essential Drug Delivery Outputs (EDDOs).
Schedule a Meeting
Fields marked with an * are required.